首页> 外国专利> Use of 10-(3R)-1-azabicyclo(2.2.2)oct-3-ylmethyl-10H-phenothiazine for the manufacture of medicament to treat rhinorea, urinary incontinence and associate disorders e.g. incontinence by imperious miction

Use of 10-(3R)-1-azabicyclo(2.2.2)oct-3-ylmethyl-10H-phenothiazine for the manufacture of medicament to treat rhinorea, urinary incontinence and associate disorders e.g. incontinence by imperious miction

机译:10-(3R)-1-氮杂双环(2.2.2)辛-3-基甲基-10H-吩噻嗪在生产用于治疗犀牛,尿失禁和相关疾病的药物中的用途无礼的失禁

摘要

Use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine (I) and its salts for the manufacture of a medicament to prevent or treat disorders, diseases and/or pathologies by selectively inhibiting of muscarinic M1 receptor, muscarinic M2 receptor and muscarinic M3 receptor, is claimed. ACTIVITY : Uropathic; Antibacterial; Fungicide. MECHANISM OF ACTION : Muscarinic M1 receptor inhibitor; Muscarinic M2 receptor inhibitor; Muscarinic M3 receptor inhibitor. The effect of (I) to inhibit the muscarinic M1 receptor was tested in Chinese hamster ovary cells using in vitro assay. The results showed that (I) exhibited an IC 5 0 value of 1.6 nM.
机译:10-[(3R)-1-氮杂双环[2.2.2]辛-3-基甲基] -10H-吩噻嗪(I)及其盐在制备用于预防或治疗疾病,疾病和/或病理的药物中的用途通过选择性抑制毒蕈碱M1受体,要求毒蕈碱M2受体和毒蕈碱M3受体。活动:空灵;抗菌;杀菌剂。作用机理:毒蕈碱型M1受体抑制剂;毒蕈碱型M2受体抑制剂;毒蕈碱M3受体抑制剂。使用体外测定法在中国仓鼠卵巢细胞中测试了(I)抑制毒蕈碱性M1受体的作用。结果显示(I)显示出1.6 nM的IC 5 0值。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号